Lyell Depreciation And Amortization vs Income Before Tax Analysis
| LYEL Stock | USD 1.17 0.04 3.31% |
Lyell Immunopharma financial indicator trend analysis is infinitely more than just investigating Lyell Immunopharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lyell Immunopharma is a good investment. Please check the relationship between Lyell Immunopharma Depreciation And Amortization and its Income Before Tax accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyell Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.
Depreciation And Amortization vs Income Before Tax
Depreciation And Amortization vs Income Before Tax Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lyell Immunopharma Depreciation And Amortization account and Income Before Tax. At this time, the significance of the direction appears to have pay attention.
The correlation between Lyell Immunopharma's Depreciation And Amortization and Income Before Tax is -0.87. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Lyell Immunopharma, assuming nothing else is changed. The correlation between historical values of Lyell Immunopharma's Depreciation And Amortization and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of Lyell Immunopharma are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Depreciation And Amortization i.e., Lyell Immunopharma's Depreciation And Amortization and Income Before Tax go up and down completely randomly.
Correlation Coefficient | -0.87 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Lyell Immunopharma income statement and is an important metric when analyzing Lyell Immunopharma profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most indicators from Lyell Immunopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lyell Immunopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyell Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.At this time, Lyell Immunopharma's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 541.02 this year, although the value of Issuance Of Capital Stock will most likely fall to 0.00.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 1.2M | 7.1M | 23.5M | 24.6M | Net Interest Income | 1.2M | 7.1M | 23.5M | 24.6M |
Lyell Immunopharma fundamental ratios Correlations
Click cells to compare fundamentals
Lyell Immunopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyell Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyell Immunopharma. If investors know Lyell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyell Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.79) | Quarterly Revenue Growth 0.36 | Return On Assets (0.19) | Return On Equity (0.33) |
The market value of Lyell Immunopharma is measured differently than its book value, which is the value of Lyell that is recorded on the company's balance sheet. Investors also form their own opinion of Lyell Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Lyell Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyell Immunopharma's market value can be influenced by many factors that don't directly affect Lyell Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyell Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyell Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyell Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.